$1.2 Billion Settlement in FTC's Suit Against Cephalon
The Federal Trade Commission's biggest settlement to date—$1.2 billion in a pay-for-delay case—came out of federal court in Philadelphia on Thursday.
May 28, 2015 at 08:00 PM
5 minute read
The Federal Trade Commission's biggest settlement to date—$1.2 billion in a pay-for-delay case—came out of federal court in Philadelphia on Thursday.
Cephalon, now owned by Teva Pharmaceutical Industries, agreed to settle a suit filed by the FTC in 2008 over the company's reverse-payment arrangements with generic drugmakers.
Reverse-payment settlements are the deals made by major pharmaceutical companies with generic drugmakers in order to keep the cheaper drugs off the market and, in this case, Cephalon had made deals with four generic drugmakers ranging from $25 million to $164 million to protect its name-brand wakefulness drug called Provigil.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250